Researchers at Ifakara Health Institute Report Findings in Global Health (Cost and cost drivers associated with setting-up a prime vendor system to complement the national medicines supply chain in Tanzania)

2020 SEP 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Daily -- Investigators publish new report on Health and Medicine - Global Health. According to news reporting originating from Dar Es Salaam, Tanzania, by NewsRx correspondents, research stated, “Economic analysis of supply chain management interventions to improve the availability of healthcare commodities at healthcare facilities is important in generating evidence for decision-makers. The current study assesses the cost and cost drivers for setting-up a public-private partnership programme in Tanzania in which all public healthcare facility orders for complementary medicines are pooled at the district level, and then purchased from one contracted supplier, the prime vendor (referred to as ‘Jazia Prime Vendor System’ (Jazia PVS)).”

Financial support for this research came from Swiss Programme for Research on Global Issues for Development (r4d); Swiss Agency for Development and Cooperation (SDC); Swiss National Science Foundation.

Our news editors obtained a quote from the research from Ifakara Health Institute, “Financial and economic costs of Jazia PVS were collected retrospectively and using the ingredients approach. The financial costs were spread over the implementation period of January 2014-July 2019. In addition, we estimated the financial rollout costs of Jazia PVS to the other 23 regions in the country over 2 years (2018-2019). A multivariate sensitivity analysis was conducted on the estimates. Jazia PVS start-up and recurrent financial costs amounted to US$2 170 989.74 and US$709 302.32, respectively. The main cost drivers were costs for short-term experts, training of staff and healthcare workers and the Jazia PVS technical and board management activities. The start-up financial cost per facility was US$2819.47 and cost per capita was US$0.37. In conclusion, the study provides useful information on the cost and cost drivers for setting-up a complementary pharmaceutical supply system to complement an existing system in low-income settings.”

According to the news editors, the research concluded: “Despite the substantial costs incurred in the initial investment and operations of the Jazia PVS, the new framework is effective in achieving the desired purpose of improving availability of healthcare commodities.”

For more information on this research see: Cost and cost drivers associated with setting-up a prime vendor system to complement the national medicines supply chain in Tanzania. Bmj Global Health, 2020;5(9):e002681.

The news editors report that additional information may be obtained by contacting August Kuwawenaruwa, Ifakara Health Institute, Dar es Salaam, Tanzania. Additional authors for this research include Kaspar Wyss, Karin Wiedenmayer and Fabrizio Tediosi.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1136/bmjgh-2020-002681. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)